잠시만 기다려 주세요. 로딩중입니다.

Review of COVID-19 Vaccines and Their Evidence in Older Adults

Annals of Geriatric Medicine and Research 2021년 25권 1호 p.4 ~ 9
Teo Shyh Poh,
소속 상세정보
 ( Teo Shyh Poh ) - Raja Isteri Pengiran Anak Saleha Hospital Department of Internal Medicine

Abstract


Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in a global pandemic and significant loss of life. Older people are vulnerable to SARS-CoV-2 infections and complications; thus, they are a priority group to receive COVID-19 vaccines. This review discusses considerations for COVID-19 vaccines for older adults. The general concepts of vaccine effectiveness in older adults are described, particularly immune senescence and vaccine development approaches to improve immunogenicity. The types of COVID-19 vaccine platforms are also described before reviewing the available, although limited, evidence from phase 3 COVID-19 vaccine trials relevant to older adults. The BNT162b2 vaccine by Pfizer-BioNTech and mRNA-1273 vaccine from Moderna demonstrated high efficacy and immunogenicity, which were also observed in older people. While the ChAdOx1 nCoV-19 vaccine (AZD1222) by AstraZeneca demonstrated some efficacy in older people, the vaccine dose requires clarification through further studies. Finally, the Ad26.COV2.S vaccine by Janssen Pharmaceuticals shows promise as a single-dose vaccine with a potential durability of response.

키워드

COVID-19; Aged; Older adults; Vaccines

원문 및 링크아웃 정보

등재저널 정보